Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06899165 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Psilocybin-Assisted Therapy for Intergenerational Trauma

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 28, 2025 to Aug 28, 2026
    • Eligibility criteria expanded, about 447 words
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 21, 2025 to Aug 28, 2025
    • Site details revised
    v3
  3. Start date: Jun 1, 2025 to Aug 21, 2025v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Rachel Yehuda
3 trials monitored
See all monitored trials
Anxiety
3,263 trials monitored
See 159 trials at risk
Depression
3,055 trials monitored
See 173 trials at risk
This is an open-label psilocybin-assisted therapy study that will examine the safety and tolerability of psilocybin-assisted therapy in the offspring of genocide survivors with mood and anxiety disorders. The study will also investigate the efficacy of psilocybin-assisted therapy in reducing symptoms such as depression, anxiety and stress, as well as changes to the psychological effects of parental exposure to genocide, and changes to psychological resilience.
Trial Details
NCT Number NCT06899165
Lead Sponsor Rachel Yehuda
Conditions
(from sponsor)		 Psychological Stress, Depression, Anxiety
Related terms Anxiety Disorders, Depression, Historical Trauma, Stress, Psychological
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov